Search Results

The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market –MRNTF), pioneering the transformation of spinal surgery through Artifici

The MEDICREA® Group, pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling and patient specific implants with its UNiD™ ASI proprietary software platform, services and technologies, announces the appointment of an independent expert.

The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market –MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling and patient specific implants with its UNiD™ ASI (Adaptive Spine Int

The MEDICREA® Group, pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling and patient specific implants with its UNiD™ ASI proprietary software platform, services and technologies, publishes sales for the first half of 2020.

The MEDICREA® Group, pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling and patient specific implants with its UNiD™ ASI proprietary software platform, services and technologies, reports its unaudited results for the first quarter of 2020.

MEDICREA® (Euronext Growth Paris : FR0004178572 – ALMED, PEA-PME eligible and OTCQX : MRNTF), announced today that it has reached more than 5,000 cases with its proprietary UNiD® ASI technology platform and using patient-specific implants manufactured by MEDICREA

The MEDICREA® Grouppublishes its 2019 IFRS annual results, as audited and approved by the Board of Directors on April 7, 2020, as well as its sales for the first quarter of 2020.

The Medicrea Group reports its unaudited results for the first half of 2019, as approved by the Board of Directors on September 16, 2019.

The MEDICREA® Group announces that it is in active discussions with potential U.S. strategic partners in the spine industry with the intention to execute one or more strategic agreements that could materialize through a takeover of the Company, establishing partnerships or distribution agreements.

The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market –MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling and patient specific implants with its UNiD™ ASI (Adaptive Spine Intelligence) proprietary software platform, services and technologies, communicates on the consequences on its activity of the COVID-19 pandemic and the measures it has taken to deal with it.